News
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
December 15
Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients,...
-
December 02– New Assigned Rate Further Validates the Commercial Value of the PreTRM® Test –
Salt Lake City – Dec 2, 2021 – Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker...
-
December 01Results confirmed that a U.S. validated proteomics predictor could be applied in low and middle income countries to help address global preterm birth challenges
Salt Lake City, – December 1, 2021 – Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...
-
November 30– Highly respected healthcare and financial leader joins Sera in its quest to improve pregnancy outcomes of mothers and babies –
Salt Lake City, Nov. 30, 2021 (PR NEWSWIRE) — Sera PrognosticsInc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...
-
November 09
Salt Lake City – November 9, 2021 – Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker...
-
November 08Noted healthcare and technology executive joins to help Sera achieve its vision as The Pregnancy Company® to improve maternal and newborn health
Salt Lake City, Nov. 8, 2021 (PR NEWSWIRE) — Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...
-
November 04– Dr. Myers to support Sera’s commitment to reduce healthcare disparities among underserved communities –
Salt Lake City, Nov. 4, 2021 (PR NEWSWIRE) —Sera Prognostics Inc., The Pregnancy Company™ (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...
-
November 03Publication illustrates the power of stratifying PreTRM® testing risk at or above a threshold of twice the average population risk of spontaneous preterm birth (sPTB).
Salt Lake City – November 3, 2021 – Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker...
-
November 02Partnership to include distribution of a children’s book with essential prenatal healthcare information and support in the form of pregnancy/NICU “care boxes”
Salt Lake City, Nov. 2, 2021 (PR NEWSWIRE) —Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...
-
October 27
Salt Lake City, Oct. 27, 2021 (PR NEWSWIRE) —Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...
-
September 28Brings extensive data science, bioinformatics and proteomics experience to foster further product innovation and informed healthcare insights into pregnancy
Salt Lake City, Sep. 28, 2021 (GLOBE NEWSWIRE) —Sera Prognostics Inc., The Pregnancy Company™ (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...
-
September 15
Salt Lake City, Sep. 15, 2021 (GLOBE NEWSWIRE) —Sera Prognostics Inc., The Pregnancy Company™ (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...
-
September 14Publication illustrates clinical benefit of combining PreTRM® testing with evidence-based interventions to improve neonatal health and reduce total health costs
Salt Lake City – September 14, 2021 – Sera Prognostics Inc., The Pregnancy Company™, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information...
-
September 13
Salt Lake City – September 13, 2021 – Sera Prognostics Inc., The Pregnancy Company™ (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...
-
August 30
Salt Lake City – August 30, 2021 – Sera Prognostics Inc., The Pregnancy Company™ (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker...
-
August 17Study demonstrates positive impact of the company’s PreTRM® test and treat strategy on improving neonatal healthcare
SALT LAKE CITY, Aug. 17, 2021 (GLOBE NEWSWIRE) — Sera Prognostics Inc., The Pregnancy Company™, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker...
-
July 14
Salt Lake City – July 14, 2021 – Sera Prognostics, Inc., The Pregnancy Company® (“Sera”), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker...
-
May 19– The PreTRM® Test Is Designed to Build a Foundation for Healthy Communities One Baby at a Time
SALT LAKE CITY, May 19, 2021 (GLOBE NEWSWIRE) — Sera Prognostics, Inc., The Pregnancy Company® (“Sera”), focused on improving maternal and neonatal health by providing innovative pregnancy...
-
May 18– Data presented at the ISPOR 2021 Conference illustrating clinical benefit as well as cost savings
Salt Lake City – May 18, 2021 – Sera Prognostics Inc., The Pregnancy Company™, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to...
-
April 28– Several prominent healthcare-focused institutional investors fund Sera to expand commercialization of the PreTRM® Test –
SALT LAKE CITY, April 28, 2021 (GLOBE NEWSWIRE) — Sera Prognostics, Inc., The Pregnancy Company® (“Sera”), focused on improving maternal and neonatal health by providing innovative...
-
April 13– Highly accomplished attorney joins Sera to develop its legal and intellectual property functions –
SALT LAKE CITY, April 13, 2021 (GLOBE NEWSWIRE) — Sera Prognostics, Inc., The Pregnancy Company®, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker...
-
March 31– Accomplished technology leader joins Sera to build and deploy its information strategy –
Salt Lake City – March 31, 2021 – Sera Prognostics, Inc., The Pregnancy Company™, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to...
-
February 15
February 15, 2021 — Sera Prognostics, Inc., a leading health diagnostics company dedicated to improving the lives of women and babies through individualized prenatal care, will be presenting at...
-
February 03– Receipt of dedicated CPT® code marks important commercialization milestone to pursue reimbursement for the PreTRM® Test –
Salt Lake City – February 3, 2021 – Sera Prognostics, Inc., The Pregnancy Company™, focused on improving maternal and neonatal health through innovative precision biomarker approaches,...
-
January 05– Patient enrollment began in November for this rigorous prospective, randomized, controlled PRIME intervention trial to demonstrate the value of implementing the PreTRM® prevention strategy to improve neonatal outcomes and lower cost of care-
SALT LAKE CITY, January 5, 2021 (GLOBE NEWSWIRE) — Sera Prognostics, Inc., The Pregnancy Company™, focused on improving maternal and neonatal health through innovative precision biomarker...
Sign up for our investor relations email list here.